Precision BioSciences Inc. (NASDAQ: DTIL)
$7.2700
+0.0100 ( +0.14% ) N/A
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
Market Data
Open
$7.2700
Previous close
$7.2600
Volume
N/A
Market cap
$55.69M
Day range
$7.2600 - $7.2600
52 week range
$6.4100 - $19.4299
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Apr 16, 2024 |
10-k | Annual reports | 105 | Mar 27, 2024 |
8-k | 8K-related | 13 | Mar 27, 2024 |
8-k | 8K-related | 20 | Mar 01, 2024 |
8-k | 8K-related | 13 | Feb 13, 2024 |
4 | Insider transactions | 1 | Jan 23, 2024 |
4 | Insider transactions | 1 | Jan 23, 2024 |
4 | Insider transactions | 1 | Jan 23, 2024 |
4 | Insider transactions | 1 | Jan 23, 2024 |
4 | Insider transactions | 1 | Jan 23, 2024 |